TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Croda International ( (GB:CRDA) ).
Croda International Plc has announced the grant of options under its Sharesave Scheme for 2023, involving several key executives and committee members. This move is part of the company’s ongoing efforts to incentivize its leadership and align their interests with shareholders, potentially impacting the company’s operational focus and stakeholder engagement positively.
The most recent analyst rating on (GB:CRDA) stock is a Hold with a £2688.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Spark’s Take on GB:CRDA Stock
According to Spark, TipRanks’ AI Analyst, GB:CRDA is a Neutral.
Croda International’s overall stock score reflects a balanced outlook. Strong financial health and positive earnings call guidance are offset by bearish technical indicators and moderate valuation. Investors should monitor revenue trends and geopolitical impacts closely.
To see Spark’s full report on GB:CRDA stock, click here.
More about Croda International
Croda International Plc operates in the specialty chemicals industry, focusing on the production of high-performance ingredients and technologies. The company is known for its innovative solutions in personal care, health care, crop care, and industrial chemicals, serving a diverse range of markets globally.
Average Trading Volume: 651,966
Technical Sentiment Signal: Sell
Current Market Cap: £3.51B
See more data about CRDA stock on TipRanks’ Stock Analysis page.